Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?

N. Milman, C. B. Svendsen, B. Søborg, A. B. Andersen (Copenhagen, Denmark)

Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Session: Different profiles of sarcoidosis and other granulomatous disorders
Session type: Thematic Poster Session
Number: 3724
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Milman, C. B. Svendsen, B. Søborg, A. B. Andersen (Copenhagen, Denmark). Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?. Eur Respir J 2011; 38: Suppl. 55, 3724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Miliary tuberculosis during treatment with anti TNF alpha – A report of three cases
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

False-negative interferon gamma release assay results in active tuberculosis: a TBNET study
Source: Eur Respir J 2015; 45: 279-283
Year: 2015


The significance of the antigen-specific IFN-γ release assay in vitro for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Significance of interferon gamma-inducible chemokines in pleural effusions
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

Interferon gamma assays in the diagnosis of TB pleuritis
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006


Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014


Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011



Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016